CARTER'S INC
CRINYSE🏆 #1888 by market capEarnings Oct 26US Equity
$39.74▼ $0.63 (−1.58%)
Market closed · at close1h—
24h▼ 1.6%
7d▼ 0.5%
14d▲ 2.8%
30d▲ 3.1%
1y▲ 59.8%
🏦Market Cap
$1.46B
Small Cap
📈Revenue Growth (YoY)
+5.2%
Slowing
📊Gross Margin
52.9%
Healthy
💵FCF Margin
14.7%
Healthy
⚖️P/S Ratio
0.5x
Cheap
Otter Score
48
Weak
📊
Analyst Ratings
Price
$39.74
Total
24
Raised
6
Lowered
3
Avg PT
$40.33
H / L
$42 / $38
| Institution | Action | Rating | Date |
|---|---|---|---|
Wells Fargo | Upgraded | Underweight → Equal Weight | 2026-06-17 |
UBS | Reiterated | Neutral | 2026-05-11 |
Citigroup | Upgraded | Neutral → Buy | 2026-01-21 |
Goldman Sachs | Reiterated | Sell | 2026-01-13 |
Barclays | Reiterated | Underweight | 2025-10-28 |
B of A Securities | Reiterated | Underperform | 2024-07-29 |
Evercore ISI Group | Reiterated | In Line | 2024-02-28 |
Wedbush | Reiterated | Neutral | 2024-02-23 |
B. Riley FBR | Reiterated | Buy | 2021-05-03 |
B. Riley Securities | Reiterated | Buy | 2021-05-03 |
Monness, Crespi, Hardt | Reiterated | Buy | 2021-05-03 |
DA Davidson | Reiterated | Buy | 2020-05-06 |
CFRA | Reiterated | Buy | 2020-05-05 |
Deutsche Bank | Reiterated | Hold | 2020-02-25 |
Macquarie | Downgraded | Outperform → Neutral | 2018-11-02 |
Piper Sandler | Upgraded | Neutral → Overweight | 2017-02-14 |
PiperJaffray | Upgraded | Neutral → Overweight | 2017-02-14 |
Monness Crespi Hardt | Upgraded | Neutral → Buy | 2016-08-08 |
Oppenheimer | Upgraded | Perform → Outperform | 2016-01-04 |
Sterne Agee | Downgraded | Buy → Neutral | 2015-06-18 |
Sterne Agee CRT | Downgraded | Buy → Neutral | 2015-06-18 |
Miller Tabak | Reiterated | Buy | 2013-04-12 |
BMO Capital | Reiterated | Market Perform | 2013-02-28 |
Bank of America | Reiterated | Buy | 2013-01-22 |
One row per institution, most recent rating